Egenskap
Itching
Klinisk navn: Pruritus
Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased disposition to experience pruritus.
Sammendrag
- Også kalt
- Itchy skin, Skin itching
- Kroppssystem
- Abnormality of the integument
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Itching, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test155 gener knyttet til Itching
Endringer i disse genene forårsaker sjeldne tilstander der Itching forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ABCB11ATP binding cassette subfamily B member 11 | Alltid | I 4 tilstander |
| ABCB4ATP binding cassette subfamily B member 4 | Alltid | I 3 tilstander |
| AMOTL1angiomotin like 1 | Alltid | I 1 tilstand |
| ATP8B1ATPase phospholipid transporting 8B1 | Alltid | I 5 tilstander |
| CCDC47coiled-coil domain containing 47 | Alltid | I 1 tilstand |
| CDSNcorneodesmosin | Alltid | I 2 tilstander |
| CLDN1claudin 1 | Alltid | I 1 tilstand |
| COL7A1collagen type VII alpha 1 chain | Alltid | I 3 tilstander |
| CST3cystatin C | Alltid | I 1 tilstand |
| DSG4desmoglein 4 | Alltid | I 1 tilstand |
| FLG2filaggrin 2 | Alltid | I 1 tilstand |
| MIA3MIA SH3 domain ER export factor 3 | Alltid | I 1 tilstand |
| OSMRoncostatin M receptor | Alltid | I 1 tilstand |
| PERPp53 apoptosis effector related to PMP22 | Alltid | I 1 tilstand |
| PLCG2phospholipase C gamma 2 | Alltid | I 1 tilstand |
| PLD4phospholipase D family member 4 | Alltid | I 1 tilstand |
| PLECplectin | Alltid | I 1 tilstand |
| SLC27A4solute carrier family 27 member 4 | Alltid | I 1 tilstand |
| ST14ST14 transmembrane serine protease matriptase | Alltid | I 1 tilstand |
| TRPV3transient receptor potential cation channel subfamily V member 3 | Alltid | I 1 tilstand |
| USP53ubiquitin specific peptidase 53 | Alltid | I 1 tilstand |
| VIPAS39VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog | Alltid | I 1 tilstand |
| VPS33BVPS33B late endosome and lysosome associated | Alltid | I 1 tilstand |
| ABCA12ATP binding cassette subfamily A member 12 | Svært ofte (80–99 %) | I 2 tilstander |
| ALOX12Barachidonate 12-lipoxygenase, 12R type | Svært ofte (80–99 %) | I 2 tilstander |
| ALOXE3arachidonate epidermal lipoxygenase 3 | Svært ofte (80–99 %) | I 2 tilstander |
| ASPRV1aspartic peptidase retroviral like 1 | Svært ofte (80–99 %) | I 2 tilstander |
| ATP2A2ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | Svært ofte (80–99 %) | I 2 tilstander |
| ATP7BATPase copper transporting beta | Svært ofte (80–99 %) | I 1 tilstand |
| CD28CD28 molecule | Svært ofte (80–99 %) | I 2 tilstander |
| CERS3ceramide synthase 3 | Svært ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Svært ofte (80–99 %) | I 2 tilstander |
| CYP4F22cytochrome P450 family 4 subfamily F member 22 | Svært ofte (80–99 %) | I 1 tilstand |
| DNASE1L3deoxyribonuclease 1L3 | Svært ofte (80–99 %) | I 1 tilstand |
| FECHferrochelatase | Svært ofte (80–99 %) | I 2 tilstander |
| KITKIT proto-oncogene, receptor tyrosine kinase | Svært ofte (80–99 %) | I 3 tilstander |
| KRT14keratin 14 | Svært ofte (80–99 %) | I 3 tilstander |
| KRT5keratin 5 | Svært ofte (80–99 %) | I 5 tilstander |
| LBRlamin B receptor | Svært ofte (80–99 %) | I 2 tilstander |
| LIPNlipase family member N | Svært ofte (80–99 %) | I 1 tilstand |
Vis 115 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| NIPAL4NIPA like domain containing 4 | Svært ofte (80–99 %) | I 2 tilstander |
| NLRP3NLR family pyrin domain containing 3 | Svært ofte (80–99 %) | I 1 tilstand |
| NR1H4nuclear receptor subfamily 1 group H member 4 | Svært ofte (80–99 %) | I 1 tilstand |
| PEPDpeptidase D | Svært ofte (80–99 %) | I 1 tilstand |
| PNPLA1patatin like domain 1, omega-hydroxyceramide transacylase | Svært ofte (80–99 %) | I 1 tilstand |
| SDR9C7short chain dehydrogenase/reductase family 9C member 7 | Svært ofte (80–99 %) | I 2 tilstander |
| SPINK5serine peptidase inhibitor Kazal type 5 | Svært ofte (80–99 %) | I 2 tilstander |
| STAT3signal transducer and activator of transcription 3 | Svært ofte (80–99 %) | I 1 tilstand |
| SULT2B1sulfotransferase family 2B member 1 | Svært ofte (80–99 %) | I 3 tilstander |
| TGM1transglutaminase 1 | Svært ofte (80–99 %) | I 2 tilstander |
| TNFRSF1BTNF receptor superfamily member 1B | Svært ofte (80–99 %) | I 2 tilstander |
| ADAadenosine deaminase | Ofte (30–79 %) | I 1 tilstand |
| ALDH3A2aldehyde dehydrogenase 3 family member A2 | Ofte (30–79 %) | I 1 tilstand |
| AQP5aquaporin 5 | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 2 tilstander |
| BRCA1BRCA1 DNA repair associated | Ofte (30–79 %) | I 1 tilstand |
| BRCA2BRCA2 DNA repair associated | Ofte (30–79 %) | I 1 tilstand |
| CARD14caspase recruitment domain family member 14 | Ofte (30–79 %) | I 1 tilstand |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CHD7chromodomain helicase DNA binding protein 7 | Ofte (30–79 %) | I 1 tilstand |
| CST6cystatin E/M | Ofte (30–79 %) | I 1 tilstand |
| DCDC2doublecortin domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| DCLRE1CDNA cross-link repair 1C | Ofte (30–79 %) | I 1 tilstand |
| EPAS1endothelial PAS domain protein 1 | Ofte (30–79 %) | I 1 tilstand |
| EPORerythropoietin receptor | Ofte (30–79 %) | I 1 tilstand |
| FHfumarate hydratase | Ofte (30–79 %) | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DRAmajor histocompatibility complex, class II, DR alpha | Ofte (30–79 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Ofte (30–79 %) | I 1 tilstand |
| IL12Ainterleukin 12A | Ofte (30–79 %) | I 1 tilstand |
| IL12RB1interleukin 12 receptor subunit beta 1 | Ofte (30–79 %) | I 1 tilstand |
| IL2RGinterleukin 2 receptor subunit gamma | Ofte (30–79 %) | I 1 tilstand |
| IL7Rinterleukin 7 receptor | Ofte (30–79 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Ofte (30–79 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Ofte (30–79 %) | I 2 tilstander |
| KIF12kinesin family member 12 | Ofte (30–79 %) | I 1 tilstand |
| KRT10keratin 10 | Ofte (30–79 %) | I 1 tilstand |
| LRP1LDL receptor related protein 1 | Ofte (30–79 %) | I 2 tilstander |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Ofte (30–79 %) | I 1 tilstand |
| MED12mediator complex subunit 12 | Ofte (30–79 %) | I 1 tilstand |
| MMEL1membrane metalloendopeptidase like 1 | Ofte (30–79 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Ofte (30–79 %) | I 1 tilstand |
| MVKmevalonate kinase | Ofte (30–79 %) | I 2 tilstander |
| MYO5Bmyosin VB | Ofte (30–79 %) | I 2 tilstander |
| NUDCD3NudC domain containing 3 | Ofte (30–79 %) | I 1 tilstand |
| PMVKphosphomevalonate kinase | Ofte (30–79 %) | I 1 tilstand |
| PORCNporcupine O-acyltransferase | Ofte (30–79 %) | I 1 tilstand |
| POU2AF1POU class 2 homeobox associating factor 1 | Ofte (30–79 %) | I 1 tilstand |
| PSMB10proteasome 20S subunit beta 10 | Ofte (30–79 %) | I 1 tilstand |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Ofte (30–79 %) | I 1 tilstand |
| RAG1recombination activating 1 | Ofte (30–79 %) | I 1 tilstand |
| RAG2recombination activating 2 | Ofte (30–79 %) | I 1 tilstand |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Ofte (30–79 %) | I 1 tilstand |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Ofte (30–79 %) | I 1 tilstand |
| SCN10Asodium voltage-gated channel alpha subunit 10 | Ofte (30–79 %) | I 1 tilstand |
| SCN11Asodium voltage-gated channel alpha subunit 11 | Ofte (30–79 %) | I 2 tilstander |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Ofte (30–79 %) | I 2 tilstander |
| SPIBSpi-B transcription factor | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 2 tilstander |
| STX3syntaxin 3 | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 2 tilstander |
| THPOthrombopoietin | Ofte (30–79 %) | I 1 tilstand |
| TNFSF15TNF superfamily member 15 | Ofte (30–79 %) | I 1 tilstand |
| TNPO3transportin 3 | Ofte (30–79 %) | I 1 tilstand |
| UNC45Aunc-45 myosin chaperone A | Ofte (30–79 %) | I 1 tilstand |
| WDR83OSWD repeat domain 83 opposite strand | Ofte (30–79 %) | I 1 tilstand |
| ALKALK receptor tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| CASTcalpastatin | Noen ganger (5–29 %) | I 1 tilstand |
| CLEC7AC-type lectin domain containing 7A | Noen ganger (5–29 %) | I 1 tilstand |
| DSPdesmoplakin | Noen ganger (5–29 %) | I 1 tilstand |
| FDPSfarnesyl diphosphate synthase | Noen ganger (5–29 %) | I 1 tilstand |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| GPNMBglycoprotein nmb | Noen ganger (5–29 %) | I 1 tilstand |
| GPR35G protein-coupled receptor 35 | Noen ganger (5–29 %) | I 1 tilstand |
| GSNgelsolin | Noen ganger (5–29 %) | I 1 tilstand |
| HSD3B7hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Noen ganger (5–29 %) | I 1 tilstand |
| IL17Finterleukin 17F | Noen ganger (5–29 %) | I 1 tilstand |
| IL17RAinterleukin 17 receptor A | Noen ganger (5–29 %) | I 1 tilstand |
| IL17RCinterleukin 17 receptor C | Noen ganger (5–29 %) | I 1 tilstand |
| KRT74keratin 74 | Noen ganger (5–29 %) | I 1 tilstand |
| LIPAlipase A, lysosomal acid type | Noen ganger (5–29 %) | I 1 tilstand |
| MST1macrophage stimulating 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MVDmevalonate diphosphate decarboxylase | Noen ganger (5–29 %) | I 1 tilstand |
| NRASNRAS proto-oncogene, GTPase | Noen ganger (5–29 %) | I 1 tilstand |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Noen ganger (5–29 %) | I 1 tilstand |
| PKP1plakophilin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| POFUT1protein O-fucosyltransferase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| POGLUT1protein O-glucosyltransferase 1 | Noen ganger (5–29 %) | I 2 tilstander |
| PPP1R13Lprotein phosphatase 1 regulatory subunit 13 like | Noen ganger (5–29 %) | I 1 tilstand |
| PSENENpresenilin enhancer, gamma-secretase subunit | Noen ganger (5–29 %) | I 1 tilstand |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| SEMA4Dsemaphorin 4D | Noen ganger (5–29 %) | I 1 tilstand |
| SLC17A9solute carrier family 17 member 9 | Noen ganger (5–29 %) | I 1 tilstand |
| SOX5SRY-box transcription factor 5 | Noen ganger (5–29 %) | I 1 tilstand |
| TCF4transcription factor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TRAF3IP2TRAF3 interacting protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ZEB2zinc finger E-box binding homeobox 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ZFYVE19zinc finger FYVE-type containing 19 | Noen ganger (5–29 %) | I 1 tilstand |
| CTNNB1catenin beta 1 | Sjelden (1–4%) | I 1 tilstand |
| GATA1GATA binding protein 1 | Sjelden (1–4%) | I 1 tilstand |
| LDHAlactate dehydrogenase A | Sjelden (1–4%) | I 1 tilstand |
| URODuroporphyrinogen decarboxylase | Sjelden (1–4%) | I 1 tilstand |
| UROSuroporphyrinogen III synthase | Sjelden (1–4%) | I 1 tilstand |
| IL31RAinterleukin 31 receptor A | Ikke registrert | I 1 tilstand |
| KLK11kallikrein related peptidase 11 | Ikke registrert | I 1 tilstand |
| PDGFRAplatelet derived growth factor receptor alpha | Ikke registrert | I 1 tilstand |
| SLCO1B1solute carrier organic anion transporter family member 1B1 | Ikke registrert | I 1 tilstand |
| SLCO1B3solute carrier organic anion transporter family member 1B3 | Ikke registrert | I 1 tilstand |
| TJP2tight junction protein 2 | Ikke registrert | I 1 tilstand |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Ikke registrert | I 1 tilstand |
| XPNPEP2X-prolyl aminopeptidase 2 | Ikke registrert | I 1 tilstand |
| ZNF341zinc finger protein 341 | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker